Evidence map›Paper›PMID 29342442›Full record

ArticleClinical lymphoma, myeloma & leukemia2018

HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab.

Elaine Chang, Gustavo Rivero, Niraj R Patel, Elizabeth Y Chiao, Syeling Lai, Kelash Bajaj, John E Mbue, Sarvari V Yellapragada

Abstract readCase Reports
In one paragraph

Article in Clinical lymphoma, myeloma & leukemia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Hiv and Lymphoma: from Epidemiology to Clinical Management.Mediterranean journal of hematology and infectious diseases · 2019
    Review
  10. New-onset insulin-dependent diabetes due to nivolumab.Endocrinology, diabetes & metabolism case reports · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elaine ChangDepartment of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX; Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston, TX. Electronic address: elainec@bcm.edu.
Gustavo RiveroDepartment of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX; Department of Medicine, Section of Hematology and Oncology, Michael E. DeBakey VA Medical Center, Houston, TX.
Niraj R PatelDepartment of Radiology, Division of Nuclear Medicine, Baylor College of Medicine, Houston, TX; Department of Radiology, Division of Nuclear Medicine, Michael E. DeBakey VA Medical Center, Houston, TX.
Elizabeth Y ChiaoCenter for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston, TX; Department of Medicine, Section of Infectious Disease, Baylor College of Medicine, Houston, TX.
Syeling LaiDepartment of Pathology, Baylor College of Medicine, Houston, TX; Department of Pathology, Michael E. DeBakey VA Medical Center, Houston, TX.
Kelash BajajDepartment of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX.
John E MbueDepartment of Pharmacy, Michael E. DeBakey VA Medical Center, Houston, TX.
Sarvari V YellapragadaDepartment of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX; Department of Medicine, Section of Hematology and Oncology, Michael E. DeBakey VA Medical Center, Houston, TX.

Funding

(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV InfectionR01CA206476 · NCI · BAYLOR COLLEGE OF MEDICINE · PI KRAMER, JENNIFER R · 2016 to 2019
$3.0M
BCM Oncology Scholars Training ProgramT32CA174647 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LIN, WEEI-CHIN · 2014 to 2018
$1.2M
NCI NIH HHS R01 CA206476NCI NIH HHS T32 CA174647
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntineoplastic Agents, ImmunologicalDrug Resistance, NeoplasmHIV InfectionsHodgkin DiseaseHumansMaleNivolumabPositron Emission Tomography Computed TomographyTreatment OutcomeAntineoplastic Agents, ImmunologicalNivolumabAnti-PD-1Autoimmune diabetesHuman immunodeficiency virusImmune checkpoint inhibitorImmune-related adverse event

Identifiers

PMID29342442
PMCPMC5809264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.